Multiple Sclerosis Treatment Market to Reach USD 31.33 Billion by 2030, Growing at a CAGR of 3.2%
Global Multiple Sclerosis Treatment Market to Reach USD 31.33 Billion by 2030, Growing at a CAGR of 3.2% Summary: The global Multiple Sclerosis (MS) Treatment market was valued at USD 25.13 billion in 2023 and is projected to grow at a steady compound annual growth rate (CAGR) of 3.2% from 2023 to 2029, reaching an estimated value of USD 31.33 billion by 2030. This growth is fueled by advancements in MS therapies, increasing prevalence of the disease, and rising healthcare expenditures across regions. Request Your Complimentary Sample Here: https://www.maximizemarketresearch.com/request-sample/54201 / A) Market Size The Multiple Sclerosis (MS) Treatment Market, valued at USD 25.13 billion in 2023, is expected to experience a consistent growth trajectory, expanding at a CAGR of 3.2%. By 2030, the market is projected to surpass USD 31.33 billion. This growth is attributed to the ongoing advancements in drug development, immunotherapies, and novel treatments for MS patie...